rs773391545

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_000726.5(CACNB4):​c.91A>C​(p.Ser31Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000917 in 1,613,498 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000093 ( 1 hom. )

Consequence

CACNB4
NM_000726.5 missense

Scores

2
8
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 5.00

Publications

0 publications found
Variant links:
Genes affected
CACNB4 (HGNC:1404): (calcium voltage-gated channel auxiliary subunit beta 4) This gene encodes a member of the beta subunit family of voltage-dependent calcium channel complex proteins. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. The protein encoded by this locus plays an important role in calcium channel function by modulating G protein inhibition, increasing peak calcium current, controlling the alpha-1 subunit membrane targeting and shifting the voltage dependence of activation and inactivation. Certain mutations in this gene have been associated with idiopathic generalized epilepsy (IGE), juvenile myoclonic epilepsy (JME), and episodic ataxia, type 5. [provided by RefSeq, Aug 2016]
CACNB4 Gene-Disease associations (from GenCC):
  • episodic ataxia type 5
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, idiopathic generalized, susceptibility to, 9
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.22039494).
BP6
Variant 2-152098386-T-G is Benign according to our data. Variant chr2-152098386-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 446974.
BS2
High AC in GnomAd4 at 12 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000726.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB4
NM_000726.5
MANE Select
c.91A>Cp.Ser31Arg
missense
Exon 2 of 14NP_000717.2O00305-1
CACNB4
NM_001005746.4
c.37A>Cp.Ser13Arg
missense
Exon 2 of 14NP_001005746.1O00305-3
CACNB4
NM_001145798.2
c.91A>Cp.Ser31Arg
missense
Exon 2 of 13NP_001139270.1O00305-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNB4
ENST00000539935.7
TSL:1 MANE Select
c.91A>Cp.Ser31Arg
missense
Exon 2 of 14ENSP00000438949.1O00305-1
CACNB4
ENST00000201943.10
TSL:1
c.91A>Cp.Ser31Arg
missense
Exon 2 of 13ENSP00000201943.5O00305-4
CACNB4
ENST00000638005.1
TSL:2
c.37A>Cp.Ser13Arg
missense
Exon 2 of 14ENSP00000489677.1O00305-3

Frequencies

GnomAD3 genomes
AF:
0.0000789
AC:
12
AN:
152146
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000844
AC:
21
AN:
248948
AF XY:
0.0000740
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000186
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000931
AC:
136
AN:
1461352
Hom.:
1
Cov.:
31
AF XY:
0.0000812
AC XY:
59
AN XY:
727014
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33468
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53366
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.000120
AC:
133
AN:
1111614
Other (OTH)
AF:
0.0000497
AC:
3
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000789
AC:
12
AN:
152146
Hom.:
0
Cov.:
33
AF XY:
0.0000673
AC XY:
5
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41422
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000176
AC:
12
AN:
68022
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000113
Hom.:
0
Bravo
AF:
0.0000831
ExAC
AF:
0.0000662
AC:
8
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
CACNB4-related disorder (1)
-
1
-
Episodic ataxia type 5;C2750887:Epilepsy, idiopathic generalized, susceptibility to, 9 (1)
-
1
-
Idiopathic generalized epilepsy (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.92
BayesDel_addAF
Benign
-0.095
T
BayesDel_noAF
Benign
-0.10
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Benign
0.087
T
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.88
D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.22
T
MetaSVM
Uncertain
-0.22
T
MutationAssessor
Benign
0.81
L
PhyloP100
5.0
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-0.56
N
REVEL
Benign
0.25
Sift
Benign
0.044
D
Sift4G
Uncertain
0.041
D
Polyphen
0.99
D
Vest4
0.36
MutPred
0.11
Loss of phosphorylation at S31 (P = 0.0039)
MVP
0.88
MPC
1.7
ClinPred
0.29
T
GERP RS
5.1
PromoterAI
-0.070
Neutral
Varity_R
0.21
gMVP
0.90
Mutation Taster
=73/27
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773391545; hg19: chr2-152954900; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.